← Open Payments lookup

KEVIN ALLISON: Open Payments

NPI 1477116952 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$33,333 in 89 payments from 12 companies in 2025. Trend: 2023 $31,007 · 2024 $12,328 · 2025 $33,333

Speaker / faculty: $17,613Consulting: $9,535Travel & lodging: $3,643Food & beverage: $2,543
CompanyPaymentsAmount
GENZYME CORPORATION10$11,279
Genentech USA, Inc.29$8,768
TG Therapeutics, Inc.14$6,297
Amgen Inc.20$5,705
E.R. Squibb & Sons, L.L.C.1$471
Biogen, Inc.3$210
Alexion Pharmaceuticals, Inc.1$175
Novartis Pharmaceuticals Corporation6$144
Takeda Pharmaceuticals U.S.A., Inc.1$114
EMD Serono, Inc.2$75

Products named: Ocrevus, BRIUMVI, UPLIZNA, ULTOMIRIS, KESIMPTA, VUMERITY, ENTYVIO, ZEPOSIA.

Industry payments across FL — which companies pay providers there.